Risks and Precautions for Combining Clonazepam and Hydrocodone

Introduction to Risks

• The American College of Physicians and other medical societies recommend avoiding the combination of clonazepam and hydrocodone due to the risk of quadrupling overdose mortality compared to opioid prescription alone, as demonstrated by a case-cohort study 1

Patient Risk Factors

• Elderly patients (≥65 years) are at significantly increased risk of opioid overdose, falls, and CNS depression when prescribed this combination 1
• Patients with respiratory compromise, such as those with COPD, asthma, or sleep apnea, face heightened risk of respiratory depression 1, 3
• Patients with hepatic impairment are at increased risk of toxicity due to reduced metabolism 1

Safe Prescribing Practices

• The Centers for Disease Control and Prevention recommend using the absolute lowest effective dosages of both medications and prescribing minimum durations of concomitant use 2
• It is essential to monitor for excessive sedation, dizziness, confusion, and respiratory depression at every clinical encounter 3
• Checking prescription drug monitoring programs (PDMPs) for concurrent controlled medications prescribed by other clinicians is crucial 4

Alternative Treatment Options

• The National Comprehensive Cancer Network recommends optimizing the opioid regimen first, considering opioid rotation, dose adjustment, or switching to non-opioid analgesics 5
• Using non-benzodiazepine anxiolytics, such as SSRIs, SNRIs, buspirone, or hydroxyzine, is a safer alternative for anxiety 2, 4

Tapering and Discontinuation

• The CDC and other medical societies recommend tapering opioids first, then benzodiazepines, when reducing this combination to minimize risk 6, 4, 1
• Tapering benzodiazepines gradually, reducing the dose by 25% every 1-2 weeks, is essential to avoid withdrawal symptoms 6, 4, 1

Education and Multidisciplinary Team Involvement

• Patients and caregivers should be counseled about signs of respiratory depression, avoiding alcohol and other CNS depressants, and naloxone availability 5, 4
• Involving pharmacists, pain specialists, mental health professionals, and substance use disorder specialists in the management of this combination is crucial 4, 1